Introduction

!
Laennec first reported in 1819 on pathological changes in the lungs in the form of irreversible dilation of the bronchi due to pulmonary infections, and used the word "bronchiectasis" [1] . Nowadays, the incidence and severity of bronchiectasis has been significantly reduced by the widespread use of antibiotics and vaccination, although it remains a health problem in developing countries because of the higher rate of infections such as tuberculosis, pertussis and rubeola [2] . Bronchiectasis is often managed medically, but surgery is the treatment of choice in cases with severe and uncontrolled symptoms and localized disease, and offers good outcomes with minimal mortality and morbidity rates [3] . The purpose of this study was to assess the surgical treatment outcomes of 277 patients with bronchiectasis.
Material and Methods
!
We reviewed 277 patients with bronchiectasis who underwent pulmonary resection in the Ghaem and Omid hospitals affiliated to Mashhad University of Medical Sciences in Iran from 1985 to 2008. All patients underwent an evaluation of clinical features, biochemical laboratory tests, chest X-ray (CXR) and CT scan. All patients underwent flexible bronchoscopy and were subsequently carefully assessed for cardiac reserve. Pulmonary function test was performed for all patients.
Abstract
! Background: Bronchiectasis is a permanent irreversible dilatation of the bronchial wall, often arising from inadequate treatment of a pulmonary infection. In recent years, the incidence of bronchiectasis has decreased mainly due to improved medical treatment of respiratory infections. However, the disease still constitutes a health problem in developing countries. Method: We reviewed 277 patients with bronchiectasis who underwent pulmonary resection in the Ghaem & Omid hospitals affiliated to Mashhad University of Medical Sciences in Iran from 1985 to 2008. The patients were evaluated for age, sex, clinical features, etiology, type of surgical procedure, morbidity, mortality and treatment outcomes. Results: A total of 277 patients were enrolled in this study [200 males (72.2 %) and 77 females (27.7 %)]. Mean patient age was 34.7 years. The most common symptom was productive cough (79.4 %). The most common etiology was pulmonary infection (77.6 %). The disease was bilateral in 62 cases (22.3 %) and the most common site of involvement was the left lower lobe (55 %). The most common surgical technique for the unilateral form was lobectomy (42.2%) and one-sided lobectomy with segmentectomy of the other side in 25 patients with bilateral bronchiectasis. Mortality and morbidity rates were 0.7 % and 15.8 %, respectively. The most common complication was wound infection (5.7 %). The mean follow-up was 4.5 years. 68.5% of patients were symptomfree at the last postoperative evaluation, 23.8 % had an improvement in their symptoms, and 7.5 % of patients showed no improvement. Statistically, complete resection had a better outcome. Conclusion: In conclusion, surgery is an acceptable treatment in bronchiectasis and has low mortality and morbidity rates. The best outcomes were observed after complete resection. In selected bilateral cases, resection was used with acceptable outcomes.
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